Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Formyl Peptide Receptor 1 (FPR1) (Middle Region) Peptide

FPR1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN977094

Quick Overview for Formyl Peptide Receptor 1 (FPR1) (Middle Region) Peptide (ABIN977094)

Target

FPR1 (Formyl Peptide Receptor 1 (FPR1))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    VACTFNFSPW TNDPKERINV AVAMLTVRGI IRFIIGFSAP MSIVAVSYGL

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-FPR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    FPR1 (Formyl Peptide Receptor 1 (FPR1))

    Background

    This gene encodes a G protein-coupled receptor of mammalian phagocytic cells that is a member of the G-protein coupled receptor 1 family. The protein mediates the response of phagocytic cells to invasion of the host by microorganisms and is important in host defense and inflammation.

    Alias Symbols: FMLP, FPR

    Protein Size: 350

    Molecular Weight

    38 kDa

    Gene ID

    2357

    NCBI Accession

    NM_002029, NP_002020

    UniProt

    P21462
You are here:
Chat with us!